OpenCapitalBeta

Calendar Stocks Metrics

/

Stocks
Telomir Pharmaceuticals, Inc.
Income Statement

Income Statement Balance Sheet Cash Flow Segments

Telomir Pharmaceuticals, Inc. Income Statement

Revenue, expenses, and profitability over time

Market Cap$88.7M

No metrics found for this filter.

Navigation

Earnings Calendar
Stocks
Pricing
About
Methodology

Connect

Claude (MCP)
ChatGPT (MCP)
Portfolio (Plaid)

Legal

Privacy Policy
Terms of Service
Cookie Policy
SEC EDGAR
support@opencapital.sh

© 2026 OpenCapital. All rights reserved.

Data sourced from SEC filings — methodology

OpenCapital is not affiliated with or endorsed by the U.S. Securities and Exchange Commission (SEC). All data is sourced from publicly available SEC filings.

OpenCapital